نتائج البحث

Trimetazidine Improves Mitochondrial Dysfunction in SOD1 G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation.

• Authors : Salvatori I; Department of Experimental Medicine, University of Roma 'La Sapienza', 00185 Rome, Italy.; IRCCS, Fondazione Santa Lucia, 00179 Rome, Italy.

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/metabolism ; Trimetazidine*/Trimetazidine*/Trimetazidine*/pharmacology ; Trimetazidine*/Trimetazidine*/Trimetazidine*/therapeutic use

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 13; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Biochemical Aspects That Lead to Abusive Use of Trimetazidine in Performance Athletes: A Mini-Review.

• Authors : Pușcaș A; Biochemistry and Chemistry of the Environmental Factors Department, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.; Ștefănescu R

Subjects: Trimetazidine*/Trimetazidine*/Trimetazidine*/pharmacology ; Trimetazidine*/Trimetazidine*/Trimetazidine*/therapeutic use; Humans

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 28; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis.

• Authors : Tong X; Wuxi Traditional Chinese Medicine Hospital, Nanjing University of Chinese Medicine, Nanjing, China.; Shen L

Subjects: Cardiomyopathy, Dilated*/Cardiomyopathy, Dilated*/Cardiomyopathy, Dilated*/drug therapy ; Trimetazidine*/Trimetazidine*/Trimetazidine*/therapeutic use; Humans

• Source: Drugs in R&D [Drugs R D] 2023 Sep; Vol. 23 (3), pp. 197-210. Date of Electronic Publication: 2023 Aug 09.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Efficacy of Trimetazidine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Contrast Coronary Intervention: A Systematic Review and Meta-Analysis (PRISMA).

• Authors : Nair, Tiny¹ (AUTHOR) ; Ray, Saumitra² (AUTHOR) ; George, Jacob³ (AUTHOR)

• Source: Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p2151. 13p.

تفاصيل العنوان

Bioequivalence and Pharmacokinetic Profiles of 2 Trimetazidine Modified-release Tablets Under Fasting and Fed Conditions in Chinese Healthy Subjects.

• Authors : Wang J; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.; Hunan Prevention and Treatment Institute of Occupational Diseases Hospital, Changsha, People's Republic of China.

Subjects: Trimetazidine*/Trimetazidine*/Trimetazidine*/adverse effects; Humans ; Therapeutic Equivalency

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Feb; Vol. 12 (2), pp. 212-218. Date of Electronic Publication: 2022 Dec 02.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Trimetazidine, an Anti-Ischemic Drug, Reduces the Antielectroshock Effects of Certain First-Generation Antiepileptic Drugs.

• Authors : Borowicz-Reutt K; Independent Unit of Experimental Neuropathophysiology, Department of Toxicology, Medical University of Lublin, PL 20-090 Lublin, Poland.; Banach M

Subjects: Epilepsy*/Epilepsy*/Epilepsy*/metabolism ; Trimetazidine*/Trimetazidine*/Trimetazidine*/pharmacology ; Trimetazidine*/Trimetazidine*/Trimetazidine*/therapeutic use

• Source: International journal of molecular sciences [Int J Mol Sci] 2022 Sep 26; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease.

• Authors : Harjoko RP; Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Diponegoro - Dr. Kariadi General Hospital, Semarang, Indonesia.; Sobirin MA

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/diagnostic imaging ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Myocardial Ischemia*/Myocardial Ischemia*/Myocardial Ischemia*/complications

• Source: Drug discoveries & therapeutics [Drug Discov Ther] 2022 Sep 17; Vol. 16 (4), pp. 177-184. Date of Electronic Publication: 2022 Aug 24.Publisher: Shandong University China-Japan Cooperation Center for Drug Discovery & Screen Country of Publication: Japan NLM ID: 101493809 Publication Model:

تفاصيل العنوان

Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine.

• Authors : Lu Y; Shanghai University of Traditional Chinese Medicine Affiliated Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200336 Shanghai, China.; Wang F

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications ; Coronary Disease*/Coronary Disease*/Coronary Disease*/complications ; Coronary Disease*/Coronary Disease*/Coronary Disease*/drug therapy

• Source: BioMed research international [Biomed Res Int] 2022 Sep 30; Vol. 2022, pp. 6098799. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1 G93A mice.

• Authors : Scaricamazza S; Division of Experimental Neuroscience, IRCCS Fondazione Santa Lucia, Via del Fosso di Fiorano 64, Rome, 00143, Italy.; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.

Subjects: Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/drug therapy ; Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/Amyotrophic Lateral Sclerosis*/metabolism ; Neurodegenerative Diseases*

• Source: British journal of pharmacology [Br J Pharmacol] 2022 Apr; Vol. 179 (8), pp. 1732-1752. Date of Electronic Publication: 2022 Jan 13.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

تفاصيل العنوان

Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure.

• Authors : Yang K; Shandong University of Traditional Chinese Medicine, Jinan 250011, China.; Xue Y

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Trimetazidine*/Trimetazidine*/Trimetazidine*/pharmacology; Adenosine Triphosphatases

• Source: BioMed research international [Biomed Res Int] 2022 Jan 19; Vol. 2022, pp. 2387860. Date of Electronic Publication: 2022 Jan 19 (Print Publication: 2022).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان